Tape
NVDA482.31 +2.46%·
TSLA198.04 -1.12%·
AMD167.55 +0.84%·
SMCI624.18 -3.07%·
AAPL224.91 +0.31%·
MSTR378.42 +5.18%·
COIN241.06 -0.92%·
PLTR28.74 +1.61%·
META512.88 +0.47%·
AMZN188.25 -0.18%·
SPY548.92 +0.21%·
QQQ472.18 +0.39%·
NVDA482.31 +2.46%·
TSLA198.04 -1.12%·
AMD167.55 +0.84%·
SMCI624.18 -3.07%·
AAPL224.91 +0.31%·
MSTR378.42 +5.18%·
COIN241.06 -0.92%·
PLTR28.74 +1.61%·
META512.88 +0.47%·
AMZN188.25 -0.18%·
SPY548.92 +0.21%·
QQQ472.18 +0.39%·
§ Entry · May 31, 2026weekly
weekly·momentum·small-cap·watchlist

Weekly Momentum Watch: Small-Cap Setups for Jun 01 – Jun 05, 2026

Small-cap momentum watch for Jun 1-5, 2026: software earnings, biotech catalyst discipline, IWM breadth, credit spreads, oil, AI and crypto themes.

June opens with the same message the tape has been giving us for weeks: momentum is available, but it is selective. The best trades are still clustering around clean earnings reactions, specific technology themes, and biotech headlines with enough detail to pull real volume. The weak trades are the ones that need a story after the move already started.

Last week in small-caps

The earnings lane did most of the work. OKTA and DELL were larger-cap tells, but their post-report strength helped set the tone for software, infrastructure, and AI-adjacent sympathy. That matters for small-cap traders because the first clean move is often not the best vehicle; the better setup can be the lower-priced name with the same theme and a tighter risk box.

Under the surface, ESTC, BOX, and CLBT showed how mid-cap software and security names can still attract momentum when the broader growth tape is firm. OUST also stayed on the radar as a lidar/automation theme name, while SOUN kept the AI-voice lane active. None of those moves should be treated as automatic continuation. The lesson is to separate theme strength from entry quality, then use the small-cap momentum scanning playbook to demand volume, news, and structure before chasing.

Biotech remained the higher-risk bucket. ASCO-related oncology attention can create sympathy bids fast, but unclear headline runners need smaller size and faster invalidation. If the catalyst is not obvious in the first read, the trade belongs in the review journal, not in full size.

Week ahead: Jun 01 – Jun 05

The first week of June is a calendar-control week. Earnings attention should stay on software, cybersecurity, AI infrastructure, consumer names, and any small-cap reports that print with real volume. I am watching confirmed calendar names first, then letting the scanner decide which lower-float sympathy names deserve attention after the bell.

Macro is the guardrail. The market will be watching the usual early-month data lane: manufacturing activity, labor-market updates, and the Friday jobs setup if the official calendar confirms the release. For small-caps, the bigger tell is whether IWM can hold breadth while high-yield spreads stay contained. If credit starts widening while oil catches a bid, the oil-controlled macro tape takes priority over single-name catalysts.

Sector themes are still straightforward: biotech around oncology headlines, AI infrastructure after last week's tech earnings reactions, quantum/automation when news is specific, crypto-adjacent names when Bitcoin liquidity improves, and energy if crude or Strait of Hormuz risk returns to the front page. The trade plan is not to predict which theme wins. It is to know which theme is active before the opening range resolves.

How we'll use this each week

Build the list on Sunday, confirm it Monday, and cut anything that does not earn attention with price and volume. The win is not catching every runner. The win is having a repeatable process, then using the post-trade review to see whether the setup, entry, and risk controls matched the plan.

Disclaimer: This content is for educational and informational purposes only. It is not financial advice, investment advice, or a recommendation to buy or sell any security. Always do your own research, manage your own risk, and consult a licensed financial professional if needed. MeliorEdge is not responsible for trading losses or decisions made based on this content.